PROGRAMA CIENTÍFICO
22 Septiembre, 2011 (jueves)

09.00-11.00 Simposio IV Colorectal Cancer

Moderadores

  • Eduardo Díaz-Rubio
    (Hospital Clínico San Carlos, Madrid)
  • Enrique Aranda
    (Hospital Reina Sofía, Córdoba)

Ponentes

  • Gabriel Capellá Munar
    Instituto Catalán de Oncología-IDIBELL, Barcelona
     “Biology of Colorectal Cancer”  
  • Jesús García-Foncillas
    CIMA, Pamplona
    ”Integration of anti-EGFR therapies with chemotherapy in metastatic colorectal cancer”   
  • Eduardo Díaz-Rubio
    Hospital Clínico San Carlos, Madrid
    “Integration of anti-VEGF therapies with chemotherapy in metastatic colorectal cancer”   
  • Rodrigo Dienstmann
    Hospital Valle de Hebrón, Barcelona
    “Novel agents in the treatment of colorectal cancer”

09.00-11.00 Simposio V  Breast cancer

Moderadores

  • Joaquín Arribas
    Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
  • Joan Albanell,
    IMIM-Hospital del Mar, Barcelona Biomedical Research Park, Barcelona, Spain

Ponentes

  • Jorge Reis-Filho
    The Institute of Cancer Research, London, UK
    “Triple negative breast cancer and PARP inhibition”
  • Eva González-Suárez
    IDIBELL (Instituto de Investigaciones Biomédicas de Bellvitge)
    Hospital Duran i Reynals, Barcelona, Spain
     “RANKL as an anticancer target”
  • Ramon Colomer
    Centro Oncológico MD Anderson España, Madrid, Spain
     “Advances in HER2 targeting”
  • Roger Gomis
    Institute for Research in Biomedicine (IRB), Barcelona, Spain
     “Breast cancer metastasis”

11.00-11.30 Café y visita a pósters  sesión II

11.30-12.30 Conferencia magistral II

Moderador

  • Alfredo Carrato.
    Hospital Universitario Ramón y Cajal. Madrid.

Ponente

  • Francisco Real
    Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center,  Madrid, Spain
     “Bladder cancer: biology looks for employment opportunities”

12.30-14.30 Simposio VI Lung cancer

Moderadores

  • Luis Montuenga
    (Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Pamplona)
  • Rafael Rosell 
    (Hospital Germans Trias i Pujol, Barcelona)

Ponentes

  • John Field
    The Roy Castle Lung Cancer Research Programme, University of Liverpool, UK
    “Progress in risk assessment and early lung cancer screening”
  • Montserrat Sánchez-Céspedes
    IDIBELL, Barcelona
    “Molecular genetics of Non Small Cell Lung cancer”
  • Rubén Pío
    Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra. Pamplona
    “Complement activation and immunotherapy in Lung Cancer”
  • Rafael Rosell
    Hospital Germans Trias I Pujol, Barcelona
    “The predictive role of signalling networks involved in advanced lung cancer: translational and clinical perspectives”

12.30-14.30 Simposio VII  Paediatric cancer, sarcomas and soft tissues tumours

Moderadores

  • José Sánchez de Toledo
    Hospital Universitario Vall d'Hebron. FIRVH. Barcelona
  • Enrique de Álava
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain

Ponentes

  • Rafael Peris-Bonet
    Registro Nacional Tumores Infantiles (RNTI). Valencia
    Childhood Cancer. Epidemiology in Spain
  • Soledad  Gallego-Melcon
    Hospital Universitario Vall d'Hebron.FIRVH.Barcelona
    Traslational research in Rhabdomyosarcomas
  • Cristina Meazza
    Fondazione IRCCS. Istituto Nazionale dei Tumori. Milano
    Non-Rhabdomyosarcoma Soft Tissue Sarcomas. Clinical and Therapeutic topics.
  • Enrique de Álava
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
    Molecular biology of soft tissue sarcomas non-Rhabdomyosarcomas

14.30-16.00 Comida y visita a pósters Sesión II

16.00-18.00 Simposio VIII Head and neck cancer

Moderadores

  • Juan Jesús Cruz 
    Hospital Universitario de Salamanca, Salamanca
  • Juan  José Grau de Castro,
    Servicio de Oncología Médica, H. Clinic i Provincial, Barcelona

Ponentes

    • José Manuel Trigo
      Hospital Universitario Virgen de la Victoria, Málaga
      Oropharynx tumours and papillomavirus infection.  Are they different entities?
    •  
    • Atanasio Pandiella
      Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain
      New clinical  targets in head and neck cancer
    • Jordi Giralt
      Hospital Universitari Vall d'Hebron. Barcelona
      What did the new radiotherapy techniques contribute  to head and neck tumour treatment?
    Ricardo Hitt
    Hospital 12 de Octubre, Madrid
    Clinical experience of head and neck tumour treatment with monoclonal antibodies

16.00-18.00 Simposio IX  Haematological cancer

Moderadores

  • Jesús San Miguel
    (Hospital Universitario de Salamanca, Salamanca)
  • Miguel Angel Piris
    (Centro Nacional de Investigaciones Oncológicas CNIO / Spanish National Cancer Research Center, Madrid, Spain)

Ponentes

  • Jordi Sierra
    Hospital Sant Pau, Barcelona
    Myeloblastic leukaemia: Towards a personalized therapy?
  • Dolors Colomer
    Hospital Clinic , Barcelona
    Chronic lymphatic leukaemia:  is targeted therapy a possibility?
  • Alberto Orfao
    Centro de Investigación del Cáncer de Salamanca CIC /Salamanca Cancer Research Center Salamanca, Spain 
    Searching for the stem cell of multiple myeloma
  • Carlos Montalbán
    Hospital Ramón y Cajal, Madrid
    Marginal lymphomas in 2011

18.00-18.30 Café y visita a pósters

18.30-19.30 Asamblea ASEICA

19.30 Coctel del congreso